Han A Lum
Department of Family Medicine, Wonkwang University Hospital, Sinyong-dong 344-2, Iksan, Jeollabuk-do 54538 South Korea.
Int J Diabetes Dev Ctries. 2022 Apr;42(2):297-304. doi: 10.1007/s13410-021-00977-x. Epub 2021 Jul 27.
Although the influenza vaccine has been proven to be effective, this common disease has high morbidity and mortality rates. Moreover, adults with diabetes are at a high risk of influenza-mediated morbidity and mortality.
With the increasing prevalence of diabetes, influenza is more lethal in diabetics; thus, we aimed to investigate the factors associated with influenza vaccination coverage in patients with diabetes.
Cross-sectional data were obtained from the Korea National Health and Nutrition Examination Survey (2016-2018). We retrospectively analyzed whether sociodemographic, health-related, and medical factors are associated with influenza vaccination coverage in patients with diabetes. We performed a complex sample logistic regression analysis and estimated the odds ratios (ORs) by adjusting for statistically significant factors.
The number of survey subjects was 18,553. The vaccine coverage rate among patients with diabetes was 60.6%. In the univariate analysis, sex, educational level, smoking, exercise, drinking, marital status, private health insurance, activity limit, economic activity, age, and EuroQol-5 Dimension scores, which were used to assess health-related quality of life, were associated with vaccination coverage. In the multivariate analysis, only age and economic activity were associated with vaccination coverage. The vaccination coverage rate was higher for people who did not undertake economic activities and who were older (OR 1.512 (1.087-2.105), OR 2.212 (1.822-2.686), respectively, < 0.001).
National interventions involving public health centers are necessary to encourage influenza immunization for patients with diabetes, especially younger patients and those who work or undertake economic activities.
尽管流感疫苗已被证明有效,但这种常见疾病的发病率和死亡率仍然很高。此外,糖尿病成年人患流感介导的发病和死亡风险很高。
随着糖尿病患病率的上升,流感对糖尿病患者的致死性更高;因此,我们旨在调查与糖尿病患者流感疫苗接种覆盖率相关的因素。
横断面数据来自韩国国家健康与营养检查调查(2016 - 2018年)。我们回顾性分析了社会人口统计学、健康相关和医疗因素是否与糖尿病患者的流感疫苗接种覆盖率相关。我们进行了复杂样本逻辑回归分析,并通过调整具有统计学意义的因素来估计优势比(OR)。
调查对象有18,553人。糖尿病患者的疫苗接种覆盖率为60.6%。在单因素分析中,用于评估健康相关生活质量的性别、教育水平、吸烟、运动、饮酒、婚姻状况、私人医疗保险、活动受限、经济活动、年龄和欧洲五维健康量表得分与疫苗接种覆盖率相关。在多因素分析中,只有年龄和经济活动与疫苗接种覆盖率相关。未从事经济活动的人和年龄较大的人的疫苗接种覆盖率较高(优势比分别为1.512(1.087 - 2.105)和2.212(1.822 - 2.686),均<0.001)。
有必要通过公共卫生中心进行国家干预,以鼓励糖尿病患者,特别是年轻患者以及工作或从事经济活动的患者接种流感疫苗。